Focused nutrition improves cardiovascular health of schizophrenic patients: BMC

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-01-24 04:30 GMT   |   Update On 2023-01-24 08:17 GMT

In a new study conducted by Alfonso Sevillano-Jimenez and team found that in patients with schizophrenia spectrum illness, the implementation of a nutritional program aimed at boosting dietary prebiotic and probiotic content significantly improves the cardio-metabolic profile. The findings of this study were published in BMC PsychiatryThe discovery of novel etiological hypotheses, such...

Login or Register to read the full article

In a new study conducted by Alfonso Sevillano-Jimenez and team found that in patients with schizophrenia spectrum illness, the implementation of a nutritional program aimed at boosting dietary prebiotic and probiotic content significantly improves the cardio-metabolic profile. The findings of this study were published in BMC Psychiatry

The discovery of novel etiological hypotheses, such the microbiota-gut-brain axis hypothesis, shows the impact of dietary and nutritional habits on mental health, which in turn affects the patient's quality of life in terms of their physical and cardiovascular health. In the context of the SARS-CoV-2 period, the objective of this study was to ascertain the effect of a dietary program targeted at increasing the intake of prebiotic and probiotic food on cardio-metabolic state in people with schizophrenia spectrum disorders.

50 people with schizophrenia spectrum disorder were the subject of a randomized clinical study (two-arm, balanced-block, double-blind, six-month intervention) during the SARS-CoV-2 quarantine period. Individual conventional dietary counseling was provided to the control group. An individualized nutritional education program with a high prebiotic and probiotic content (dairy and fermented foods, high-fibre fruit, green leafy vegetables, whole grains, etc.) was developed for the intervention group. At the beginning, three, and six months, information on cardiovascular state was gathered. Anthropometric measurements were also examined monthly.

The key findings of this study were;

1.Following follow-up, 44 patients underwent analysis.

2.At the beginning of the intervention and after six months, all anthropometric indicators showed statistically significant changes (p 0.05).

3.A clinically meaningful improvement (lower in cardiovascular risk) was seen in the intervention group at six months as a result of a 27.4% drop in the prevalence of the risk factors associated with the metabolic syndrome across all of its components.

In conclusion, In the context of the global SARS-CoV-2 pandemic, the development of a dietary-nutritional intervention with a high symbiotic content in patients with schizophrenia spectrum disorders has been postulated as an effective and clinically significant therapy for lowering cardiovascular risk factors and improving metabolic outcomes. These dietary suggestions may act as an adjuvant in people with schizophrenia spectrum disorders who have metabolic syndrome, increasing pharmaceutical tolerance and enhancing physical health. By serving as a cornerstone of the multimodal approach and moderating lifestyles through dietary-nutritional education, nursing plays a significant role in obtaining optimal health outcomes.

Reference:

Sevillano-Jiménez, A., Romero-Saldaña, M., García-Mellado, J. A., Carrascal-Laso, L., García-Rodríguez, M., Molina-Luque, R., & Molina-Recio, G. (2022). Impact of high prebiotic and probiotic dietary education in the SARS-CoV-2 era: improved cardio-metabolic profile in schizophrenia spectrum disorders. In BMC Psychiatry (Vol. 22, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1186/s12888-022-04426-9

Tags:    
Article Source : BMC Psychiatry

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News